Advanced Analysis of OCT/OCTA Images for Accurately Differentiating Between Glaucoma and Healthy Eyes Using Deep Learning Techniques

利用深度学习技术对OCT/OCTA图像进行高级分析,以准确区分青光眼和健康眼睛

阅读:1

Abstract

PURPOSE: To evaluate the discriminative power of optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) images, identifying the best image combination for differentiating glaucoma from healthy eyes using deep learning (DL) with a convolutional neural network (CNN). METHODS: This cross-sectional study included 157 subjects contributing 1,106 eye scans. We used en-face images of the superficial and choroid layers for OCTA-based vessel density and OCT-based structural thickness of the macula (M) and optic disc (D). Images were preprocessed, resized, and normalized for CNN analysis. The CNN architecture had two components: one extracted features for each image type (OCT-D, OCT-M, OCTA-D, OCTA-M), while the second combined these features to classify eyes as healthy or glaucomatous. Performance was measured by accuracy, sensitivity, specificity, and area under the curve (AUC). RESULTS: For OCT images, the D+M combination outperformed disc (D) or macula (M) alone in three of the four metrics. For OCTA images, D+M also performed better than D or M alone, with D+M outperforming disc (D) in all criteria. Across all metrics for combined OCT+OCTA images, D+M performed better than D or M alone, and the macula (M) outperformed the disc (D). In disc (D) imaging, OCTA outperformed both OCT and OCT+OCTA in accuracy, sensitivity, and specificity, while OCT+OCTA had a higher AUC. OCTA consistently outperformed OCT and OCT+OCTA across all metrics for combined D+M images. CONCLUSION: The OCTA D+M combination performed best, followed by the OCT+OCTA D+M combination. When both en-face images are available, OCTA is preferred. Always include both disc and macula images for optimal diagnosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。